Exicure, Inc. (NASDAQ:XCUR – Get Free Report) shares rose 4.5% during trading on Wednesday . The stock traded as high as $2.80 and last traded at $2.79. Approximately 16,393 shares changed hands during trading, an increase of 23% from the average daily volume of 13,370 shares. The stock had previously closed at $2.67.
Exicure Stock Up 4.5%
The business’s fifty day moving average is $3.70 and its two-hundred day moving average is $4.43. The firm has a market cap of $17.77 million, a price-to-earnings ratio of -3.62 and a beta of 3.62.
Exicure (NASDAQ:XCUR – Get Free Report) last posted its quarterly earnings data on Wednesday, March 25th. The company reported ($0.46) earnings per share (EPS) for the quarter, topping the consensus estimate of ($18.60) by $18.14.
Exicure Company Profile
Exicure is a clinical‐stage biotechnology company pioneering the development of next‐generation genetic medicines through its proprietary spherical nucleic acid (SNA) delivery platform. This nanotechnology‐based approach is designed to facilitate the intracellular delivery of oligonucleotide therapeutics, addressing longstanding challenges in targeting hard‐to‐reach tissues such as the central nervous system.
The company’s pipeline encompasses programs for neurological disorders—including Huntington’s disease, Parkinson’s disease and Alzheimer’s disease—as well as exploratory efforts in dermatological indications and oncology.
See Also
- Five stocks we like better than Exicure
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for Exicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exicure and related companies with MarketBeat.com's FREE daily email newsletter.
